Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division PRESS RELEASE Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division Required majority of shareholders vote in... View Article
Launch of our first commercial batches of PFMD PRESS RELEASE Unither Pharmaceuticals launches first commercial batches of Preservative-Free Multidose Ophthalmic products Coutances, France – [December 11,... View Article
Advanced liquid solutions for better patient outcomes Flexible Packaging and Delivery Systems for the OTC Market Unither Pharmaceuticals provides a wide range of customizable liquid delivery systems,... View Article
Ophthalmics at Butantã site, São Paulo Enhancing ophthalmic care: the role of multidose with preservative (MDWP) In ophthalmology, multidose with preservative (MDWP) droppers remain a cost-effective and... View Article
BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage PRESS RELEASE BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases... View Article
Scientific Review – Ophthalmology – Age-related Macular Degeneration (AMD) This scientific review delves into collaborative research conducted by teams from Unither Développement Bordeaux alongside partners
Join us at Europharm SMC Europharm SMC is the official European Association representing medium sized pharmaceutical companies in the EU Our mission is: To support our... View Article
30 year anniversary Press release Unither Pharmaceuticals celebrates 30 years of innovation and expertise November 29, 2023, Paris – Unither Pharmaceuticals, a... View Article
Manufacturing of registration batches of PXT3003 in single unit doses Successful manufacturing of the three registration batches of PXT3003 oral solution sachets in the United States (U.S.)
